🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New preprint from Prof David K. Chang Nigel B. Jamieson & colleagues Clonal evolutionary analysis reveals patterns of malignant transformation in #PancreaticCancer from Intraductal Papillary Mucinous IPMN Neoplasms (IPMN) biorxiv.org/content/10.110… Phylogenetic analysis identifies two distinct

New study investigating the genomic progression of IPMN to PDAC using for the first time WGS 🧬 ➡️Preprint data available now on BioRxiv📓 Pancreas Verona Antonio Pea Prof David K. Chang IHPBA AISP AICEP

Huge collaboration between UofG Cancer Sciences UofG MVLS Pancreas Verona. It would not have happened without Antonio Pea Claudio Luchini Aldo Scarpa, rita lawlor Roberto Salvia 💪🙏

GPs and pharmacists! Get your free place at our evening webinar on 18th Sept to find out about the PERT shortage and guidance for what to do if a patient is running low or cannot get PERT. Book now: bit.ly/3YTLrTI #PCUKStudyDay

elxw.fa.em3.oraclecloud.com/hcmUI/Candidat… Clinical arch Fellowship programme in Cancer Glasgow & Edinburgh. Huge opportunity! Please apply.

The Glasgow Coma Scale at 50. One of the very, very few scores that withstand the test of time. #GCS #Trauma

Prof Steve Wigmore presents an outstanding The Royal College of Surgeons of Edinburgh Presidential Lecture at the HKSH 12th Li Shu Pui Symposium. Delighted to have this collaborative initiative fostering sharing of excellence, research and innovation between colleagues in HK and UK.

Huge congratulations Juan! So well deserved!!!

New paper in Gut Journal from Fredrik Thege & colleagues MD Anderson Cancer Center, just in time for #AACRPan24: Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas gut.bmj.com/content/early/…

Interesting preclinical study from Prof David K. Chang & colleagues University of Glasgow Sequential ATR and PARP Inhibition Overcomes Acquired DNA Damaging Agent Resistance in #PancreaticCancer biorxiv.org/content/10.110… Addressing PARP/platinum resistance that develops over time. Some of these

Shoutout to Anirban Maitra during Julie Fleshman’s remarks at PanCAN Scientific Summit. One of our very first grantees who’s now an amazing mentor and leader in the field 💜

tic work Russell, Hollie and the team!

Sorry i mean “nice work”!!!

Can’t agree more ❤️

This Giving Day, we're proudly supporting cancer research at UofG ❤️ Hear from Prof Chris Halsey, who shares what impact philanthropic support can have for UofG Cancer Sciences, providing world-class treatment for patients & representing Glasgow as a leader in cancer research in the

Please listen to the debate and make sure you know the symptoms of #pancreaticcancer. It might save your life. 👏 to all who advocate and research earlier detection and treatment methods. Nigel B. Jamieson PrecisionPanc Prof David K. Chang Jamieson Spatial Lab Lesley Goodburn scottishparliament.tv/meeting/member…

There is 'snow' place like the University of Glasgow! Campus has been transformed into a magical winter wonderland ❄️ Stay safe & warm out there, folks! #Snow #Glasgow #TeamUofG

😀I was wondering when this would come out - this is so exciting‼️ 🤔I know some may say this is a rare population, and it is 👉🏼BUT a ~40% response in >=2nd line #PancreaticCancer is still very, very clinically meaningful👏🏼 🙏🏼AND - we HAVE TO remember to test for this🧬🧬🧬🧬🧬🧬

I’m delighted to have been elected Royal Society of Edinburgh President from April 2025. I’m grateful to the Fellows of the RSE for their support. Looking forward to working with you in the coming years, and further extending our collaborations in Scotland, the U.K. and at international level.

Dr. Prof David K. Chang and colleagues provide in vitro evidence of a novel therapeutic strategy to overcome acquired resistance to PARP inhibitor and platinum in #PDAC, using sequential exposure to ceralasertib and olaparib. 💡 Learn more: go.nature.com/3Zdg06k